A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Clinical trial NCT01808612 · COMPLETED

Trial details

NCT number: NCT01808612
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2013-03-01
Primary completion: 2014-07-01
Enrollment: 513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.